Amazing. You’ve got Missling, Tomlison, and Barwicki, plus maybe (though I doubt it) a lawyer looking at the PRs and nobody thinks to review, correct or update the boilerplate language. And we’re supposed to believe they can do filings with drug regulators, etc. without errors? By the way, take a look at the company descriptor on iHub and how badly out of date it is. You’d think Tomlinson or Barwicki would have it updated!
Market Data 
Markets 
AI
